PAPER Iwatsubo T, Iwata A, Suzuki K, Ihara R, Arai H, Ishii K, Senda M, Ito K, Ikeuchi T, Kuwano R, Matsuda H, Sun CK, Beckett LA, Petersen RC, Weiner MW MW, Aisen PS PS, Donohue MC, Alzheimer's Disease Neuroimaging Initiative
SEARCH RESULTS
256058 RESULTS
PAPER Hartmann H, Hornburg D, Czuppa M, Bader J, Michaelsen M, Farny D, Arzberger T, Mann M, Meissner F, Edbauer D
Proteomics and C9orf72 neuropathology identify ribosomes as poly-GR/PR interactors driving toxicity
Life Science Alliance. 16 May 2018. DOI: 10.26508/lsa.201800070PAPER Czerkowicz J, Chen W, Wang Q, Shen C, Wager C, Stone I, Stebbins C, Lamb M, Setser J, Cantone G, Graham D
Pan-Tau Antibody Biib076 Exhibits Promising Safety and Biomarker Profile in Cynomolgus Monkey Toxicity Study
Alzheimer's & Dementia, July 2017, Volume 13, Issue 7S, Part 26, p1271PAPER Catalano S, Grundman M, Schneider LS, DeKosky S, Morgan R, Higgin M, Pribyl J, Mozzoni K, Izzo NJ, Safferstein H, Lickliter J
A Two-Part, Double-Blind, Placebo-Controlled, Phase 1 Study of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Ct1812 in Healthy Volunteers
Alzheimer's & Dementia, July 2016, Volume 12, Issue 7S, Part 24, pp1183-4.PAPER Wunderlich G, Schultheis C, Link J, Schultz A, Voelk C
Investigation of Pharmacokinetic Drug-Drug Interaction Following Oral Administration of BI 409306 and Donepezil in Healthy Subjects
Alzheimer's & Dementia, July 2017, Volume 13, Issue 7S, Part 19, p935PAPER Wunderlich G, Thamer C, Roehrle M, Garcia Jr M, Frölich L, Dubois B
Study Design and Characteristics of Two Phase II Proof-of-Concept Clinical Trials of the pde9 Inhibitor Bi 409306 in Early Alzheimer's Disease
Alzheimer's & Dementia, July 2016, Volume 12, Issue 7S, Part 16, pp820-1.PAPER Geier M
Lithium as augmentation for major depressive disorder
Mental Health Clinician: July 2012, Vol. 2, No. 1, pp. 15-17.PAPER Parker WF, Gorges RJ, Gao YN, Zhang Y, Hur K, Gibbons RD
Association Between Groundwater Lithium and the Diagnosis of Bipolar Disorder and Dementia in the United States
JAMA Psychiatry. Published online May 23, 2018.PAPER György B, Lööv C, Zaborowski MP, Takeda S, Kleinstiver BP, Commins C, Kastanenka K, Mu D, Volak A, Giedraitis V, Lannfelt L, Maguire CA, Joung JK, Hyman BT, Breakefield XO, Ingelsson M
CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease
Mol Ther Nucleic Acids. Volume 11, p429–440, 1 June 2018PAPER Itzhaki RF, Wozniak MA
Apolipoprotein E: Microbial Friend or Foe?
In: Apoprotein Research, Eds: LR Penfield and RT Nelson 2009. Nova Science Publishers Inc., New York.PAPER Olah M, Menon V, Habib N, Taga M, Yung C, Cimpean M, Khairalla A, Dionne D, Hopp S, Frosch MP, Hyman BT, Beach TG, Sarkis R, Cosgrove GR, Helgager J, Golden JA, Pennell PB, Schneider JA, Bennett DA, Regev A, Elyaman W, Bradshaw EM, De Jager PL
A single cell-based atlas of human microglial states reveals associations with neurological disorders and histopathological features of the aging brain
bioRχiv. June 11, 2018PAPER Schwalbe G
Die Arachnoidalraum ein Lymphraum und sein Zusammenhang mit den Perichorioidalraum. [The arachnoidal space as a lymphatic space with connection to the perichoroidal compartment.].
Zbl. Med. Wiss. 1869; 7, 465–467.PAPER Bradbury MW, Cserr HF, Johnston MG
Experimental Biology of the Lymphatic Circulation
Elsevier, Amsterdam, 1985PAPER LoPresti P
Tau in oligodendrocytes takes neurons in sickness and in health
Int J Mol Sci. 2018 Aug 15.PAPER Kang J, Lim L, Song J